# The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19

> **NCT04805086** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 5 (estimated)

## Conditions studied

- Pulmonary Fibrosis
- Interstitial Lung Disease
- Covid19

## Interventions

- **BIOLOGICAL:** MON002

## Key facts

- **NCT ID:** NCT04805086
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-08
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-03-05
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04805086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04805086, "The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04805086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*